Credit Suisse Reiterates an 'Outperform' on Medco Health Solutions (MHS); Implications of FEP Loss; Lowering Estimates and Target Price
Tweet Send to a Friend
Credit Suisse reiterates an 'Outperform' on Medco Health Solutions (NYSE: MHS), PT lowered from $74 to $70.
Credit Suisse analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Credit Suisse analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
